EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View Raised

• click to rate

  Posted by Two Blokes Apr 24 - Filed in Stock - 2 views
  
  Edwards Lifesciences' first-quarter 2025 performance benefits from its differentiated portfolio of therapies to treat patients with structural heart disease.